Conmed (CNMD) Non-Current Assets (2010 - 2026)

Conmed has reported Non-Current Assets for 17 years, with the latest figure at $1.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 0.86% year-over-year to $1.6 billion; the trailing twelve-month figure through Mar 2026 stood at $6.6 billion (changed 0.5% YoY), and the FY2025 full-year result was $1.7 billion, down 0.8% from the prior year.
• Non-Current Assets for Q1 2026 stood at $1.6 billion, down from $1.7 billion in the prior quarter.
• The five-year high for Non-Current Assets was $1.7 billion in Q3 2022, with the low at $1.3 billion in Q1 2022.
• Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $1.7 billion in 2025.
• Annual changes were most pronounced in 2023 — Non-Current Assets soared 31.8% — and 2024, when it retreated 2.66%.
• Conmed's Non-Current Assets stood at $1.7 billion in 2022, then slipped by 1.86% to $1.7 billion in 2023, then decreased by 1.08% to $1.7 billion in 2024, then fell by 0.8% to $1.7 billion in 2025, then slipped by 0.52% to $1.6 billion in 2026.
• The last three Non-Current Assets figures came in at $1.6 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.